Parents of twins who share a rare illness that could affect the ability to walk have described the “nightmare” battle they face with the NHS to access a free drug.
Givinostat, a medicine that can slow the progression of Duchenne muscular dystrophy, is being offered at no cost by a drug firm while it awaits NHS approval. The drug can prolong the time children with the condition can walk.
-copy-29e15046.jpeg?w=600)
